IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Outlook Therapeutics Inc (ONSGBP)

CUSIP: 69012T206 | X1 | 176 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Rosalind Advisors, Inc.450,000
1.5% of portfolio›$2.4M
StyleTurnoverLocationFiled
Rosalind Advisors, Inc.
450,000$2.4M1.5%GrowthHighToronto, Australia2024-10-30